A prospective phase II study of neoadjuvant chemoradiotherapy (CRT) for resectable esophageal squamous cell carcinoma was conducted from May 1993 to March 1996.
Missing: sca_esv= f977441fd745688c
The Pediatric Oncology Group conducted a phase II study to evaluate the activity of carboplatin in children 5 years or younger with progressive optic ...
Missing: sca_esv= f977441fd745688c
Dec 1, 2023 · CAC can be equally well assessed on routine non-gated chest CT, which is often available. This study aims to determine the clinical ...
Missing: sca_esv= f977441fd745688c
Our study identifies a 32-gene classifier that can be used to predict response to neoadjuvant CRT in SCC. However, because of the molecular diversity ...
Missing: sca_esv= f977441fd745688c
Treatment with atorvastatin to the National Cholesterol Educational ...
pubmed.ncbi.nlm.nih.gov › ...
Background: Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol (LDL-C) levels. However, there is no long-term survival study ...
Missing: sca_esv= f977441fd745688c
The study regimen consisting of 2 cycles of neoadjuvant therapy was completed without a clinically significant QOL deterioration. A transient increase in ...
Missing: sca_esv= f977441fd745688c
RhoC had high specificity (88%) in detecting invasive carcinomas with metastatic potential. Of the invasive carcinomas smaller than 1 cm, RhoC was highly ...
Missing: sca_esv= f977441fd745688c
Purpose: This study was designed to evaluate neoadjuvant intensified chemotherapy in potentially resectable or unresectable liver metastases (LM) from ...
Missing: sca_esv= f977441fd745688c
In order to show you the most relevant results, we have omitted some entries very similar to the 8 already displayed.
If you like, you can repeat the search with the omitted results included. |